Compass Therapeutics Inc. (CMPX): Price and Financial Metrics
CMPX Price/Volume Stats
| Current price | $1.37 | 52-week high | $2.34 |
| Prev. close | $1.42 | 52-week low | $0.77 |
| Day low | $1.36 | Volume | 303,700 |
| Day high | $1.46 | Avg. volume | 438,601 |
| 50-day MA | $1.74 | Dividend yield | N/A |
| 200-day MA | $1.52 | Market Cap | 188.50M |
CMPX Stock Price Chart Interactive Chart >
Compass Therapeutics Inc. (CMPX) Company Bio
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel bispecific targeting PD-1 and PD-L1, and a portfolio of bispecific and monoclonal antibodies at various stages of pre-clinical development. The company was founded by Thomas J. Schuetz on March 20, 2018 and is headquartered in Boston, MA.
CMPX Price Returns
| 1-mo | -25.14% |
| 3-mo | 8.73% |
| 6-mo | -6.80% |
| 1-year | -20.35% |
| 3-year | -58.98% |
| 5-year | N/A |
| YTD | -12.18% |
| 2023 | -68.99% |
| 2022 | 58.68% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...